![Jean Christophe Renondin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean Christophe Renondin
Directeur/Membre du Conseil chez
Juvenescence Ltd.
Profil
Jean-Christophe Renondin currently works at Advanced Biological Laboratories SA, as Independent Director, Cognate BioServices, Inc., as Director, Juvenescence Ltd., as Director from 2020, and Vesalius Biocapital Partners SARL, as Managing Partner from 2023.
Dr. Renondin also formerly worked at Xytis, Inc., as Director, Lumira Capital Investment Management, Inc., as Managing Director, Kuros Biosurgery Holding AG, as Director-Executive Board, Cytheris SA, as Director, Zealand Pharma A, as Director from 2006 to 2009, Novagali Pharma SA, as Director, Viscogliosi Brothers Acquisition Corp., as Director, ABL Diagnostics SA, as Director, AgeX Therapeutics, Inc., as Independent Director, and Innovation Capital SASU, as Managing Partner in 2009.
Dr. Renondin received his Masters Business Admin degree in 1991 from Tuck School of Business at Dartmouth and doctorate degree in 1984 from Universite Paris Cite.
Postes actifs de Jean Christophe Renondin
| Sociétés | Poste | Début |
|---|---|---|
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 20/05/2020 |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Directeur/Membre du Conseil | - |
Advanced Biological Laboratories SA
 Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Operates as a diagnostic and medical software company | Directeur/Membre du Conseil | - |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Private Equity Investor | 01/06/2023 |
Anciens postes connus de Jean Christophe Renondin
| Sociétés | Poste | Fin |
|---|---|---|
| VISCOGLIOSI BROTHERS ACQUISITION CORP. | Directeur/Membre du Conseil | 07/02/2021 |
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 01/01/2009 |
Innovation Capital SASU
 Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation. | Private Equity Investor | 01/10/2009 |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 31/03/2006 |
| AGEX THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Jean Christophe Renondin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Xytis, Inc.
 Xytis, Inc. BiotechnologyHealth Technology Develops & discovers CNS drug candidates | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
ABL Diagnostics SA
 ABL Diagnostics SA Financial ConglomeratesFinance Operates as an holding company with interest in providing real estate and industrial construction services | Finance |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs for biosurgery, tissue repair and regeneration | Commercial Services |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation. | Finance |
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Operates as a diagnostic and medical software company | Technology Services |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Manufactures cell-based therapeutics products | Health Technology |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Finance |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viscogliosi Brothers Acquisition Corp.
 Viscogliosi Brothers Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
